Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis (Q81004068)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2005

Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists’ Collaboration meta-analysis

Language	Label	Description	Also known as
English	Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis	scientific article published on 01 November 2005	Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists’ Collaboration meta-analysis

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

author name string

Varughese GI

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lip GY

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

851-853

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16079882%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001926

0 references

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and hypertension physiopathology and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

How well are hypertension and albuminuria treated in type II diabetic patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

More evidence on blocking the renin–angiotensin–aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke in patients with diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights into the biology of diabetic vascular disease: what's new?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 2 diabetes mellitus: a cardiovascular perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001926

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81004068&oldid=2055612229"